Content deleted Content added
added Category:Pyrazolecarboxamides using HotCat |
m Bot: Deprecating Template:Cite doi and some minor fixes |
||
| Line 39: | Line 39: | ||
}} |
}} |
||
'''AB-CHFUPYCA''' is a compound that was first identified as a component of [[synthetic cannabis]] products in Japan in 2015.<ref>{{Cite |
'''AB-CHFUPYCA''' is a compound that was first identified as a component of [[synthetic cannabis]] products in Japan in 2015.<ref>{{Cite journal | doi = 10.1007/s11419-015-0283-8| title = A new pyrazole-carboxamide type synthetic cannabinoid AB-CHFUPYCA [N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-3-(4-fluorophenyl)-1H-pyrazole-5-carboxamide] identified in illegal products| journal = Forensic Toxicology| year = 2015| last1 = Uchiyama | first1 = N. | last2 = Asakawa | first2 = K. | last3 = Kikura-Hanajiri | first3 = R. | last4 = Tsutsumi | first4 = T. | last5 = Hakamatsuka | first5 = T. }}</ref> The pharmacological properties of this compound have not been formally studied or reported in the scientific literature, but its discovery in recreational drug products suggests that it is intended be a [[cannabinoid]] [[agonist]]. Although AB-CHFUPYCA contains structural elements common to the synthetic cannabinoid designer drugs [[AB-PINACA]] and [[AB-FUBINACA]], it can also be considered an analog of the traditional [[pyrazole]] cannabinoid receptor 1 antagonist [[rimonabant]]. |
||
==See also== |
==See also== |
||
Revision as of 22:42, 29 August 2015
 | |
| Identifiers | |
|---|---|
| |
| Chemical and physical data | |
| Formula | C22H29FN4O2 |
| Molar mass | 400.50 g/mol g·mol−1 |
AB-CHFUPYCA is a compound that was first identified as a component of synthetic cannabis products in Japan in 2015.[1] The pharmacological properties of this compound have not been formally studied or reported in the scientific literature, but its discovery in recreational drug products suggests that it is intended be a cannabinoid agonist. Although AB-CHFUPYCA contains structural elements common to the synthetic cannabinoid designer drugs AB-PINACA and AB-FUBINACA, it can also be considered an analog of the traditional pyrazole cannabinoid receptor 1 antagonist rimonabant.
See also
References
- ^ Uchiyama, N.; Asakawa, K.; Kikura-Hanajiri, R.; Tsutsumi, T.; Hakamatsuka, T. (2015). "A new pyrazole-carboxamide type synthetic cannabinoid AB-CHFUPYCA [N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-3-(4-fluorophenyl)-1H-pyrazole-5-carboxamide] identified in illegal products". Forensic Toxicology. doi:10.1007/s11419-015-0283-8.